HER2-HER3 dimer quantification by FLIM-FRET predicts breast cancer metastatic relapse independently of HER2 IHC status

類似資料

• HER2-HER3 Heterodimer Quantification by FRET-FLIM and Patient Subclass Analysis of the COIN Colorectal Trial
  著者:: Barber, Paul R, 等
  出版事項: (2019)
• Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging
  著者:: Rowley, Mark I., 等
  出版事項: (2016)
• Correction: Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging.
  著者:: Mark I Rowley, 等
  出版事項: (2016-01-01)
• Correction: Robust Bayesian Fluorescence Lifetime Estimation, Decay Model Selection and Instrument Response Determination for Low-Intensity FLIM Imaging
  著者:: Rowley, Mark I., 等
  出版事項: (2016)
• Assessment of EGFR/HER2 dimerization by FRET-FLIM utilizing Alexa-conjugated secondary antibodies in relation to targeted therapies in cancers
  著者:: Waterhouse, Benjamin R., 等
  出版事項: (2011)